Adia Nutrition, Inc. (ADIA)

OTCMKTS · Delayed Price · Currency is USD
0.205
-0.003 (-1.44%)
Mar 6, 2026, 3:07 PM EST
156.25%
Market Cap 19.35M
Revenue (ttm) 6.38K
Net Income (ttm) -181.07K
Shares Out 94.40M
EPS (ttm) -0.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 67,700
Average Volume 28,359
Open 0.211
Previous Close 0.208
Day's Range 0.180 - 0.215
52-Week Range 0.018 - 0.278
Beta -10.57
RSI 54.02
Earnings Date Apr 20, 2026

About Adia Nutrition

Adia Nutrition, Inc. offers medical treatments and nutritional supplements. It operates in three segments: Biolete, Adia Med, and Adia Labs. The company provides autologous hematopoietic stem cell transplantation (AHSCT) treatments for multiple sclerosis patients. It also operates Adia Med, a clinic to perform stem cell treatments, and Adia Labs, which procures and sells stem cell products to outside clinics or Adia Med. In addition, the company offers nutritional supplements and biologic products. It sells its products on a direct-to-consumer ... [Read more]

Industry Shell Companies
Sector Financials
Founded 1999
Employees 3
Stock Exchange OTCMKTS
Ticker Symbol ADIA
Full Company Profile

Financial Performance

News

There is no news available yet.